Trial Profile
A questionnaire-based survey to identify issues with patient compliance and to develop solutions to improve Rebif compliance and improve outcomes
Status:
Active, no longer recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 21 Mar 2007
Price :
$35
*
At a glance
- Drugs Interferon beta-1a (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 21 Mar 2007 New trial record.